Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ranjit Kumar Harwansh"'
Autor:
Rutvi Agrawal, Priyanka Jurel, Rohitas Deshmukh, Ranjit Kumar Harwansh, Akash Garg, Ashwini Kumar, Sudarshan Singh, Ajay Guru, Arun Kumar, Vinoth Kumarasamy
Publikováno v:
Pharmaceutics, Vol 16, Iss 7, p 869 (2024)
Since the earliest days, people have been employing herbal treatments extensively around the world. The development of phytochemical and phytopharmacological sciences has made it possible to understand the chemical composition and biological properti
Externí odkaz:
https://doaj.org/article/e2877d0b85184d0f8e9a9399c8fc17f7
Autor:
Mohammad Akhlaquer Rahman, Abuzer Ali, Mohamed Rahamathulla, Shahana Salam, Umme Hani, Shadma Wahab, Musarrat Husain Warsi, Mohammad Yusuf, Amena Ali, Vineet Mittal, Ranjit Kumar Harwansh
Publikováno v:
Polymers, Vol 15, Iss 3, p 542 (2023)
The goal of current research was to develop a new form of effective drug, curcumin-loaded solid lipid nanoparticles (Cur-SLNs) and test its efficacy in the treatment of lung cancer. Different batches of SLNs were prepared by the emulsification–ultr
Externí odkaz:
https://doaj.org/article/0b940b6074484c25b39212a5bfa74333
Autor:
Ranjit Kumar Harwansh, Kartik Chandra Patra, Surendra Kumar Pareta, Jagadish Singh, Mohammed Akhlaquer Rahman
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 47, Iss 4, Pp 769-778 (2011)
The present investigation aims to evaluate an isotropic and thermodynamically stable nanoemulsion formulation for transdermal delivery of glycyrrhizin (GZ), with minimum surfactant and cosurfactant (Smix) concentrations that could improve its solubil
Externí odkaz:
https://doaj.org/article/0d9091f18517493f9d59e5ac14fcc018
Publikováno v:
Pharmaceutical Nanotechnology. 10:210-219
Background: β-artemether (BAT) and lumefantrine (LFT) combination therapies are well recognized for the treatment of malaria. However, the current conventional formulations have several drawbacks. Objective: The study aims to develop novel lipid nan